Know Cancer

or
forgot password


Phase 2/Phase 3
18 Years
75 Years
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information


Inclusion Criteria:



- Patients with cT2-T3a prostate cancer

Exclusion Criteria:

- Men>75 years

- Men<18 years

- Prior hormonal therapy

- Prior radiation or chemotherapy

- Prior investigational agents

- Life expectancy > 10 years

- Prior malignancy within the last five years

- Any other serious medical or psychiatric condition

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind

Principal Investigator

Giovanni Luca Gravina, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of L'Aquila

Authority:

Italy: Ethics Committee

Study ID:

SMBC142

NCT ID:

NCT00421694

Start Date:

Completion Date:

Related Keywords:

  • Prostate Cancer
  • Prostatic Neoplasms

Name

Location